ABLYX
Price
$27.75
Change
+$0.39 (+1.43%)
Updated
Jul 1 closing price
Net Assets
3.3B
VIVAX
Price
$69.68
Change
+$0.70 (+1.01%)
Updated
Jul 1 closing price
Net Assets
188.77B
Interact to see
Advertisement

ABLYX vs VIVAX

Header iconABLYX vs VIVAX Comparison
Open Charts ABLYX vs VIVAXBanner chart's image
American Beacon Large Cap Value Y
Price$27.75
Change+$0.39 (+1.43%)
VolumeN/A
Net Assets3.3B
Vanguard Value Index I
Price$69.68
Change+$0.70 (+1.01%)
VolumeN/A
Net Assets188.77B
ABLYX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ABLYX vs. VIVAX commentary
Jul 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABLYX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. ABLYX (3.3B). VIVAX pays higher dividends than ABLYX: VIVAX (2.06) vs ABLYX (1.59). ABLYX was incepted earlier than VIVAX: ABLYX (16 years) vs VIVAX (33 years). ABLYX (0.73) is less costly to investors than VIVAX (0.17). ABLYX is a more actively managed with annual turnover of: 26.00 vs. VIVAX (9.00). VIVAX has a lower initial minimum investment than ABLYX: VIVAX (3000) vs ABLYX (100000). VIVAX annual gain was more profitable for investors over the last year : 10.71 vs. ABLYX (3.22). VIVAX return over 5 years is better than : 77.19 vs. ABLYX (32.63).
ABLYXVIVAXABLYX / VIVAX
Total Expense Ratio0.730.17429%
Annual Report Gross Expense Ratio0.730.17429%
Fund Existence16 years33 years-
Gain YTD6.8954.467154%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets3.3B189B2%
Annual Yield % from dividends1.592.0677%
Returns for 1 year3.2210.7130%
Returns for 3 years16.1432.9449%
Returns for 5 years32.6377.1942%
Returns for 10 years3.04111.233%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LADQX19.60N/A
N/A
Lord Abbett Developing Growth R2
SCSDX18.42N/A
N/A
Allspring Common Stock Admin
PJFPX73.74N/A
N/A
PGIM Jennison Growth R4
LYFIX12.28N/A
N/A
AlphaCentric Life Sciences & Hlthcare I
PMICX10.87N/A
N/A
Putnam Multi-Asset Income C